Shares | Value | |||||
COMMON STOCKS - 90.3% | ||||||
Aerospace & Defense - 11.5% | ||||||
CACI International, Inc. - Class A(a) | 1,712 | $736,382 | ||||
Science Applications International Corp. | 3,414 | 401,316 | ||||
1,137,698 | ||||||
Capital Markets - 25.7%(b) | ||||||
Bakkt Holdings, Inc.(a)(c) | 8,954 | 169,410 | ||||
Galaxy Digital Holdings Ltd.(a) | 41,730 | 487,335 | ||||
MarketAxess Holdings, Inc. | 1,218 | 244,246 | ||||
OTC Markets Group, Inc. - Class A | 5,235 | 255,991 | ||||
Tradeweb Markets, Inc. - Class A | 4,003 | 424,318 | ||||
Urbana Corp. - Class A | 143,618 | 496,447 | ||||
WisdomTree, Inc. | 45,360 | 449,518 | ||||
2,527,265 | ||||||
Global Exchanges - 39.7%(b) | ||||||
ASX Ltd. | 9,872 | 395,581 | ||||
Cboe Global Markets, Inc. | 3,232 | 549,634 | ||||
Deutsche Boerse AG | 2,992 | 612,798 | ||||
Japan Exchange Group, Inc. | 21,216 | 494,855 | ||||
London Stock Exchange Group PLC | 3,853 | 457,832 | ||||
Nasdaq, Inc. | 7,430 | 447,732 | ||||
Singapore Exchange Ltd. | 60,085 | 420,296 | ||||
TMX Group Ltd. | 18,934 | 526,917 | ||||
3,905,645 | ||||||
IT Services - 3.7% | ||||||
Applied Digital Corp.(a)(c) | 25,139 | 149,577 | ||||
Digital Garage, Inc. | 14,048 | 215,707 | ||||
365,284 | ||||||
Securities and Commodities Exchange - 9.7% | ||||||
CME Group, Inc. | 2,106 | 414,040 | ||||
Intercontinental Exchange, Inc. | 3,969 | 543,316 | ||||
957,356 | ||||||
TOTAL COMMON STOCKS (Cost $8,136,788) | 8,893,248 | |||||
TOTAL INVESTMENTS - 90.3% (Cost $8,136,788) | $8,893,248 | |||||
Money Market Deposit Account - 12.8%(d)(e) | 1,259,630 | |||||
Liabilities in Excess of Other Assets - (3.1)% | (306,639) | |||||
TOTAL NET ASSETS - 100.0% | $9,846,239 | |||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-23226
Listed Funds Trust
(Exact name of registrant as specified in charter)
615 East Michigan Street
Milwaukee, WI 53202
(Address of principal executive offices) (Zip code)
Gregory C. Bakken, President
Listed Funds Trust
c/o U.S. Bancorp Fund Services, LLC
777 East Wisconsin Avenue, 6th Floor
Milwaukee, WI 53202
(Name and address of agent for service)
(414) 516-3097
Registrant’s telephone number, including area code
Date of fiscal year end: December 31
Date of reporting period: June 30, 2024
Item 1. Reports to Stockholders.
(a) |
Horizon Kinetics Blockchain Development ETF | ||
BCDF (Principal U.S. Listing Exchange: NYSE) | ||
Semi-Annual Shareholder Report | June 30, 2024 |
Fund Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Horizon Kinetics Blockchain Development ETF | $42 | 0.85% |
Net Assets | $9,846,239 |
Number of Holdings | 21 |
Portfolio Turnover | 1% |
Security Type | (% of Net Assets) |
Common Stocks | 90.3% |
Cash & Other | 9.7% |
Top 10 Issuers | (% of Net Assets) |
CACI International, Inc. | 7.5% |
Deutsche Boerse AG | 6.2% |
Cboe Global Markets, Inc. | 5.6% |
Intercontinental Exchange, Inc. | 5.5% |
TMX Group Ltd. | 5.4% |
Urbana Corp. | 5.0% |
Japan Exchange Group, Inc. | 5.0% |
Galaxy Digital Holdings Ltd. | 5.0% |
London Stock Exchange Group PLC | 4.7% |
WisdomTree, Inc. | 4.6% |
Top Ten Countries | (% of Net Assets) |
United States | 53.5% |
Canada | 10.4% |
Japan | 7.2% |
Germany | 6.2% |
United Kingdom | 4.7% |
Singapore | 4.3% |
Australia | 4.0% |
Cash & Other | 9.7% |
Horizon Kinetics Blockchain Development ETF | PAGE 1 | TSR_SAR_53656G209 |
Horizon Kinetics Blockchain Development ETF | PAGE 2 | TSR_SAR_53656G209 |
Horizon Kinetics Energy and Remediation ETF | ||
NVIR (Principal U.S. Listing Exchange: NYSE) | ||
Semi-Annual Shareholder Report | June 30, 2024 |
Fund Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Horizon Kinetics Energy and Remediation ETF | $44 | 0.85% |
Net Assets | $3,556,220 |
Number of Holdings | 38 |
Portfolio Turnover | 0% |
Top Sectors | (% of Net Assets) |
Energy | 72.4% |
Industrial | 19.5% |
Basic Materials | 2.2% |
Consumer, Non-cyclical | 1.4% |
Cash & Other | 4.5% |
Top 10 Issuers | (% of Net Assets) |
Exxon Mobil Corp. | 8.0% |
Diamondback Energy, Inc. | 4.8% |
Williams Cos., Inc. | 4.4% |
CES Energy Solutions Corp. | 3.9% |
Cheniere Energy, Inc. | 3.8% |
EQT Corp. | 3.9% |
Texas Pacific Land Corp. | 3.7% |
PrairieSky Royalty Ltd. | 3.7% |
Suncor Energy, Inc. | 3.7% |
ConocoPhillips | 3.5% |
Horizon Kinetics Energy and Remediation ETF | PAGE 1 | TSR-SAR-53656G514 |
Horizon Kinetics Inflation Beneficiaries ETF | ||
INFL (Principal U.S. Listing Exchange: NYSE) | ||
Semi-Annual Shareholder Report | June 30, 2024 |
Fund Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Horizon Kinetics Inflation Beneficiaries ETF | $43 | 0.85% |
Net Assets | $750,792,382 |
Number of Holdings | 42 |
Portfolio Turnover | 6% |
Security Type | (% of Net Assets) |
Common Stocks | 96.9% |
Publicly Traded Partnerships | 0.7% |
Cash & Other | 2.4% |
Top 10 Issuers | (% of Net Assets) |
Texas Pacific Land Corp. | 7.0% |
Landbridge Co. LLC | 6.4% |
PrairieSky Royalty Ltd. | 6.0% |
Viper Energy, Inc. | 5.9% |
Wheaton Precious Metals Corp. | 5.8% |
Intercontinental Exchange, Inc. | 4.6% |
Franco-Nevada Corp. | 3.8% |
CACI International, Inc. | 3.4% |
Archer-Daniels-Midland Co. | 3.3% |
Bunge Global SA | 3.3% |
Horizon Kinetics Inflation Beneficiaries ETF | PAGE 1 | TSR_SAR_53656F623 |
Horizon Kinetics Medical ETF | ||
MEDX (Principal U.S. Listing Exchange: NASDAQ) | ||
Semi-Annual Shareholder Report | June 30, 2024 |
Fund Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Horizon Kinetics Medical ETF | $44 | 0.85% |
Net Assets | $17,748,940 |
Number of Holdings | 35 |
Portfolio Turnover | 0% |
Top Sectors | (% of Net Assets) |
Consumer, Non-cyclical | 94.5% |
Cash & Other | 5.5% |
Top 10 Issuers | (% of Net Assets) |
Eli Lilly & Co. | 17.1% |
AbbVie, Inc. | 7.4% |
Amgen, Inc. | 5.9% |
Novartis AG | 5.8% |
AstraZeneca PLC | 5.5% |
Merck & Co., Inc. | 4.7% |
Regeneron Pharmaceuticals, Inc. | 4.3% |
Johnson & Johnson | 4.2% |
Bristol-Myers Squibb Co. | 4.2% |
Pfizer, Inc. | 4.1% |
Horizon Kinetics Medical ETF | PAGE 1 | TSR-SAR-53656G563 |
Horizon Kinetics SPAC Active ETF | ||
SPAQ (Principal U.S. Listing Exchange: NASDAQ) | ||
Semi-Annual Shareholder Report | June 30, 2024 |
Fund Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Horizon Kinetics SPAC Active ETF | $43 | 0.85% |
Net Assets | $17,528,978 |
Number of Holdings | 42 |
Portfolio Turnover | 68% |
Top Sectors | (% of Net Assets) |
Special Purpose Acquisition Companies | 99.9% |
Cash & Other | 0.1% |
Top 10 Issuers | (% of Net Assets) |
Centurion Acquisition Corp. | 5.0% |
Spring Valley Acquisition Corp. II | 5.0% |
Graf Global Corp. | 4.7% |
SilverBox Corp. III | 4.7% |
IB Acquisition Corp. | 4.7% |
Learn CW Investment Corp. | 4.6% |
Legato Merger Corp. III | 4.6% |
Haymaker Acquisition Corp. 4 | 4.5% |
Bowen Acquisition Corp. | 4.5% |
Inflection Point Acquisition Corp. II | 4.4% |
Horizon Kinetics SPAC Active ETF | PAGE 1 | TSR-SAR-53656G555 |
(b) | Not applicable. |
Item 2. Code of Ethics.
Not applicable for semi-annual reports.
Item 3. Audit Committee Financial Expert.
Not applicable for semi-annual reports.
Item 4. Principal Accountant Fees and Services.
Not applicable for semi-annual reports
Item 5. Audit Committee of Listed Registrants.
Not applicable for semi-annual reports
Item 6. Investments.
(a) | Schedule of Investments is included within the financial statements filed under Item 7 of this Form. |
(b) | Not Applicable. |
Item 7. Financial Statements and Financial Highlights for Open-End Investment Companies.
(a) |
Page | |||
Schedule of Investments | |||
Financial Highlights | |||
(a) | Non-income producing security. |
(b) | To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly affect those industries or sectors. |
(c) | All or a portion of this security is on loan as of June 30, 2024. The total market value of these securities was $280,284 which represented 2.8% of net assets. |
(d) | The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based on market conditions and is subject to change daily. The rate as of June 30, 2024 was 5.28%. |
(e) | All or a portion of this deposit is held as collateral for securities lending. The value of this deposit held as collateral for securities lending as of June 30, 2024 is $311,329. |
1 |
Level 1 | Level 2 | Level 3 | Total | |||||||||
Investments: | ||||||||||||
Common Stocks | $8,893,248 | $ — | $ — | $8,893,248 | ||||||||
Total Investments | $8,893,248 | $ — | $— | $8,893,248 | ||||||||
2 |
Shares | Value | |||||
COMMON STOCKS - 95.5% | ||||||
Chemicals-Specialty - 2.2% | ||||||
Ecolab, Inc. | 330 | $ 78,540 | ||||
Diagnostic Kits - 1.4% | ||||||
IDEXX Laboratories, Inc.(a) | 105 | 51,156 | ||||
Electronic Measuring Instruments - 4.9% | ||||||
Badger Meter, Inc. | 440 | 81,994 | ||||
Itron, Inc.(a) | 920 | 91,043 | ||||
173,037 | ||||||
Engineering-Research & Development Services - 1.7% | ||||||
Fluor Corp.(a) | 1,430 | 62,276 | ||||
Machinery-Electrical - 1.5% | ||||||
Franklin Electric Co., Inc. | 555 | 53,458 | ||||
Machinery-General Industrial - 1.3% | ||||||
IDEX Corp. | 230 | 46,276 | ||||
Machinery-Pumps - 5.4% | ||||||
Flowserve Corp. | 1,495 | 71,910 | ||||
Watts Water Technologies, Inc. - Class A | 295 | 54,094 | ||||
Xylem, Inc. | 500 | 67,815 | ||||
193,819 | ||||||
Oil Companies -Exploration & Production - 22.3% | ||||||
Chesapeake Energy Corp. | 1,425 | 117,121 | ||||
ConocoPhillips | 1,100 | 125,818 | ||||
Diamondback Energy, Inc. | 850 | 170,161 | ||||
EOG Resources, Inc. | 970 | 122,094 | ||||
EQT Corp. | 3,705 | 137,011 | ||||
Occidental Petroleum Corp. | 1,905 | 120,072 | ||||
792,277 | ||||||
Oil Comp-Integrated - 11.7% | ||||||
Exxon Mobil Corp. | 2,453 | 282,389 | ||||
Suncor Energy, Inc. | 3,465 | 132,017 | ||||
414,406 | ||||||
Oil-Field Services - 19.6% | ||||||
Calfrac Well Services Ltd.(a) | 11,935 | 37,069 | ||||
CES Energy Solutions Corp. | 24,705 | 139,020 | ||||
Enerflex Ltd. | 8,325 | 44,955 | ||||
Liberty Energy, Inc. | 3,465 | 72,384 | ||||
Oil States International, Inc.(a) | 11,300 | 50,172 | ||||
Schlumberger NV | 2,115 | 99,786 | ||||
Secure Energy Services, Inc. | 8,705 | 77,040 | ||||
STEP Energy Services Ltd.(a)(b) | 16,600 | 49,496 | ||||
TETRA Technologies, Inc.(a) | 13,600 | 47,056 | ||||
Trican Well Service Ltd. | 22,415 | 78,957 | ||||
695,935 | ||||||
Shares | Value | |||||
Oil-US Royalty Trusts - 10.6% | ||||||
Permian Basin Royalty Trust | 4,760 | $53,597 | ||||
PrairieSky Royalty Ltd. | 6,955 | 132,152 | ||||
Sabine Royalty Trust | 493 | 31,892 | ||||
San Juan Basin Royalty Trust | 6,533 | 26,524 | ||||
Texas Pacific Land Corp. | 180 | 132,169 | ||||
376,334 | ||||||
Pipelines - 8.2% | ||||||
Cheniere Energy, Inc. | 785 | 137,242 | ||||
Williams Cos., Inc. | 3,655 | 155,337 | ||||
292,579 | ||||||
Water Treatment Systems - 4.7% | ||||||
Energy Recovery, Inc.(a) | 2,440 | 32,428 | ||||
Pentair PLC | 945 | 72,453 | ||||
Veralto Corp. | 666 | 63,583 | ||||
168,464 | ||||||
TOTAL COMMON STOCKS (Cost $3,161,763) | 3,398,557 | |||||
TOTAL INVESTMENTS - 95.5% (Cost $3,161,763) | $3,398,557 | |||||
Money Market Deposit Account - 4.4%(c) | 155,529 | |||||
Other Assets in Excess of Liabilities - 0.1% | 2,134 | |||||
TOTAL NET ASSETS - 100.0% | $3,556,220 | |||||
(a) | Non-income producing security. |
(b) | Security is exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may only be resold in transactions exempt from registration to qualified institutional investors. As of June 30, 2024, the value of these securities total $49,496 or 1.4% of the Fund’s net assets. |
(c) | The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based on market conditions and is subject to change daily. The rate as of June 30, 2024 was 5.28%. |
3 |
Level 1 | Level 2 | Level 3 | Total | |||||||||
Investments: | ||||||||||||
Common Stocks | $3,398,557 | $ — | $ — | $3,398,557 | ||||||||
Total Investments | $3,398,557 | $— | $— | $3,398,557 | ||||||||
4 |
Shares | Value | |||||
COMMON STOCKS - 96.9% | ||||||
Aerospace & Defense - 3.4% | ||||||
CACI International, Inc. - Class A (a) | 59,605 | $ 25,637,899 | ||||
Agricultural Operations - 7.6% | ||||||
Archer-Daniels-Midland Co. | 419,035 | 25,330,666 | ||||
Bunge Global SA | 230,265 | 24,585,394 | ||||
Wilmar International Ltd. | 3,300,467 | 7,549,491 | ||||
57,465,551 | ||||||
Building Production-Wood - 2.2% | ||||||
West Fraser Timber Co. Ltd. | 212,217 | 16,313,121 | ||||
Diversified Minerals - 0.0%(b) | ||||||
Lithium Royalty Corp. (a)(c) | 100,000 | 482,333 | ||||
Fertilizer - 1.7% | ||||||
Nutrien Ltd. | 246,957 | 12,572,581 | ||||
Global Exchanges - 11.9% | ||||||
ASX Ltd. | 427,131 | 17,115,592 | ||||
Deutsche Boerse AG | 114,403 | 23,431,127 | ||||
Japan Exchange Group, Inc. | 620,376 | 14,470,041 | ||||
Singapore Exchange Ltd. | 2,226,063 | 15,571,354 | ||||
TMX Group Ltd. | 673,145 | 18,733,044 | ||||
89,321,158 | ||||||
Insurance Brokers - 3.2% | ||||||
Marsh & McLennan Cos., Inc. | 113,120 | 23,836,646 | ||||
Investment Management-Advisor Services - 0.7% | ||||||
Sprott, Inc. | 134,559 | 5,569,397 | ||||
Medical Labs & Testing Services - 2.4% | ||||||
Charles River Laboratories International, Inc. (a) | 86,352 | 17,838,596 | ||||
Medical-Biomedical-Genetics - 0.8% | ||||||
Royalty Pharma PLC - Class A | 222,139 | 5,857,805 | ||||
Metal-Diversified - 7.8% | ||||||
Altius Minerals Corp. | 339,546 | 5,258,143 | ||||
Cameco Corp. | 440,667 | 21,680,816 | ||||
Deterra Royalties Ltd. | 4,228,753 | 11,268,466 | ||||
Glencore PLC | 3,649,082 | 20,808,273 | ||||
59,015,698 | ||||||
Metal-Iron - 1.5% | ||||||
Labrador Iron Ore Royalty Corp. | 215,106 | 4,574,550 | ||||
Mesabi Trust | 367,540 | 6,332,714 | ||||
Trident Royalties PLC (a) | 1,000,000 | 602,973 | ||||
11,510,237 | ||||||
Shares | Value | |||||
Oil Companies -Exploration & Production - 7.2% | ||||||
Landbridge Co. LLC - Class A (a) | 2,058,823 | $47,661,752 | ||||
Topaz Energy Corp. | 350,895 | 6,154,478 | ||||
53,816,230 | ||||||
Oil-US Royalty Trusts - 23.4% | ||||||
Permian Basin Royalty Trust | 735,052 | 8,276,686 | ||||
PrairieSky Royalty Ltd. | 2,366,419 | 44,964,296 | ||||
Sabine Royalty Trust (c) | 76,398 | 4,942,187 | ||||
San Juan Basin Royalty Trust (c) | 885,237 | 3,594,062 | ||||
Sitio Royalties Corp. - Class A | 712,971 | 16,833,245 | ||||
Texas Pacific Land Corp. | 71,756 | 52,688,278 | ||||
Viper Energy, Inc. | 1,177,521 | 44,192,363 | ||||
175,491,117 | ||||||
Pipelines - 3.1% | ||||||
Cheniere Energy, Inc. | 131,840 | 23,049,587 | ||||
Precious Metals - 13.3% | ||||||
Franco-Nevada Corp. | 239,664 | 28,404,977 | ||||
Metalla Royalty & Streaming Ltd. (c) | 390,000 | 1,084,200 | ||||
Osisko Gold Royalties Ltd. | 1,192,871 | 18,584,930 | ||||
Sandstorm Gold Ltd. | 1,490,856 | 8,110,257 | ||||
Wheaton Precious Metals Corp. | 831,205 | 43,571,766 | ||||
99,756,130 | ||||||
Real Estate Operations- Development - 1.5% | ||||||
St Joe Co. | 213,108 | 11,657,008 | ||||
Securities & Commodities Exchange - 4.6% | ||||||
Intercontinental Exchange, Inc. | 250,385 | 34,275,203 | ||||
Transport-Marine - 0.6% | ||||||
Clarkson PLC | 82,220 | 4,302,862 | ||||
TOTAL COMMON STOCKS (Cost $723,082,788) | 727,769,159 | |||||
PUBLICLY TRADED PARTNERSHIPS - 0.7% | ||||||
Oil Companies -Exploration & Production - 0.7% | ||||||
Dorchester Minerals LP | 157,192 | 4,849,373 | ||||
TOTAL PUBLICLY TRADED PARTNERSHIPS (Cost $1,487,114) | 4,849,373 | |||||
TOTAL INVESTMENTS - 97.6% (Cost $724,569,902) | $732,618,532 | |||||
Money Market Deposit Account - 7.4% (d)(e) | 55,647,181 | |||||
Liabilities in Excess of Other Assets - (5.0)% | (37,473,331) | |||||
TOTAL NET ASSETS - 100.0% | $750,792,382 | |||||
5 |
(a) | Non-income producing security. |
(b) | Represents less than 0.05% of net assets. |
(c) | All or a portion of this security is on loan as of June 30, 2024. The total market value of these securities was $3,104,859 which represented 0.4% of net assets. |
(d) | The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based on market conditions and is subject to change daily. The rate as of June 30, 2024 was 5.28%. |
(e) | All or a portion of this deposit is held as collateral for securities lending. The value of this deposit held as collateral for securities lending as of June 30, 2024 is $3,284,744. |
6 |
Level 1 | Level 2 | Level 3 | Total | |||||||||
Investments: | ||||||||||||
Common Stocks | $727,769,159 | $ — | $ — | $727,769,159 | ||||||||
Publicly Traded Partnerships | 4,849,373 | — | — | 4,849,373 | ||||||||
Total Investments | $732,618,532 | $— | $— | $732,618,532 | ||||||||
7 |
Shares | Value | |||||
COMMON STOCKS - 94.5% | ||||||
Cosmetics & Toiletries - 0.7% | ||||||
Haleon PLC - ADR | 14,082 | $116,317 | ||||
Diagnostic Equipment - 0.1% | ||||||
Pacific Biosciences of California, Inc.(a) | 11,517 | 15,778 | ||||
Medical Imaging Systems - 0.4% | ||||||
GE HealthCare Technologies, Inc. | 960 | 74,803 | ||||
Medical-Biomedical-Genetics - 32.7%(b) | ||||||
2seventy bio, Inc.(a) | 17,275 | 66,509 | ||||
Allogene Therapeutics, Inc.(a) | 19,194 | 44,722 | ||||
Alnylam Pharmaceuticals, Inc.(a) | 2,880 | 699,840 | ||||
Amgen, Inc. | 3,359 | 1,049,519 | ||||
Beam Therapeutics, Inc.(a) | 9,597 | 224,858 | ||||
Bicycle Therapeutics PLC - ADR(a) | 14,396 | 291,375 | ||||
Biogen, Inc.(a) | 3,119 | 723,047 | ||||
Bluebird Bio, Inc.(a) | 36,468 | 35,892 | ||||
CRISPR Therapeutics AG(a) | 10,557 | 570,184 | ||||
Editas Medicine, Inc.(a) | 31,670 | 147,899 | ||||
Intellia Therapeutics, Inc.(a) | 14,396 | 322,182 | ||||
Ionis Pharmaceuticals, Inc.(a) | 12,476 | 594,606 | ||||
Lantern Pharma, Inc.(a) | 28,791 | 134,454 | ||||
Mural Oncology PLC(a) | 2,304 | 7,234 | ||||
Regeneron Pharmaceuticals, Inc.(a) | 720 | 756,742 | ||||
Replimune Group, Inc.(a) | 14,396 | 129,564 | ||||
Salarius Pharmaceuticals, Inc.(a) | 3,886 | 9,326 | ||||
5,807,953 | ||||||
Medical-Drugs - 60.0%(b) | ||||||
AbbVie, Inc. | 7,678 | 1,316,931 | ||||
Alkermes PLC(a) | 23,033 | 555,095 | ||||
AstraZeneca PLC - ADR | 12,476 | 973,003 | ||||
Bristol-Myers Squibb Co. | 17,755 | 737,365 | ||||
Eli Lilly & Co. | 3,359 | 3,041,171 | ||||
Galectin Therapeutics, Inc.(a)(c) | 53,742 | 121,457 | ||||
GSK PLC - ADR | 11,265 | 433,703 | ||||
Johnson & Johnson | 5,107 | 746,439 | ||||
Merck & Co., Inc. | 6,718 | 831,688 | ||||
Novartis AG - ADR | 9,597 | 1,021,697 | ||||
Pfizer, Inc. | 25,912 | 725,018 | ||||
Vanda Pharmaceuticals, Inc.(a) | 25,912 | 146,403 | ||||
10,649,970 | ||||||
Medical-Generic Drugs - 0.6% | ||||||
Sandoz Group AG - ADR(c) | 1,920 | 69,504 | ||||
Viatris, Inc. | 3,572 | 37,971 | ||||
107,475 | ||||||
TOTAL COMMON STOCKS (Cost $9,307,134) | 16,772,296 | |||||
Contracts | Value | |||||
RIGHTS - 0.0%(d) | ||||||
Medical-Biomedical-Genetics - 0.0%(d) | ||||||
Pathos AI, Inc., Expires 01/29/2025, Exercise Price $1.00(a)(e) | 23,992 | $0 | ||||
TOTAL RIGHTS (Cost $0) | 0 | |||||
TOTAL INVESTMENTS - 94.5% (Cost $9,307,134) | $16,772,296 | |||||
Money Market Deposit Account - 6.4%(f)(g) | 1,136,329 | |||||
Liabilities in Excess of Other Assets - (0.9)% | (159,685) | |||||
TOTAL NET ASSETS - 100.0% | $17,748,940 | |||||
(a) | Non-income producing security. |
(b) | To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly affect those industries or sectors. |
(c) | All or a portion of this security is on loan as of June 30, 2024. The total market value of these securities was $188,560 which represented 1.1% of net assets. |
(d) | Represents less than 0.05% of net assets. |
(e) | Fair value determined using significant unobservable inputs in accordance with procedures established by and under the supervision of the Adviser, acting as Valuation Designee. These securities represented $0 or 0.0% of net assets as of June 30, 2024. |
(f) | The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based on market conditions and is subject to change daily. The rate as of June 30, 2024 was 5.28%. |
(g) | All or a portion of this deposit is held as collateral for securities lending. The value of this deposit held as collateral for securities lending as of June 30, 2024 is $190,500. |
8 |
Level 1 | Level 2 | Level 3 | Total | |||||||||
Investments: | ||||||||||||
Common Stocks | $16,772,296 | $ — | $ — | $16,772,296 | ||||||||
Rights | — | — | —(a) | — | ||||||||
Total Investments | $16,772,296 | $— | $— | $16,772,296 | ||||||||
(a) | The Fund held a Level 3 security at the end of the period valued at $0. The security classified as Level 3 is deemed immaterial and did not |
9 |
Shares | Value | |||||
SPECIAL PURPOSE ACQUISITION COMPANIES (SPACS) - 99.6% | ||||||
99 Acquisition Group, Inc. - Class A(a) | 47,015 | $493,657 | ||||
Ai Transportation AcquisitionCorp.(a) | 70,522 | 730,608 | ||||
Alchemy Investments Acquisition Corp. 1(a) | 47,015 | 504,471 | ||||
Ares Acquisition Corp. II(a) | 72,503 | 773,607 | ||||
Bayview Acquisition Corp. - Class A(a) | 47,015 | 481,434 | ||||
Black Hawk Acquisition Corp. - Class A(a) | 25,000 | 253,500 | ||||
Bowen Acquisition Corp.(a) | 74,283 | 783,686 | ||||
Centurion Acquisition Corp.(a) | 87,500 | 874,125 | ||||
Chenghe Acquisition II Co.(a) | 30,800 | 308,308 | ||||
Churchill Capital Corp. IX(a) | 70,000 | 708,400 | ||||
Colombier Acquisition Corp. II - Class A(a) | 47,013 | 483,059 | ||||
ESH Acquisition Corp. - Class A(a) | 37,612 | 392,293 | ||||
Flag Ship Acquisition Corp.(a) | 70,000 | 700,700 | ||||
Graf Global Corp.(a) | 82,500 | 825,066 | ||||
Haymaker Acquisition Corp. 4(a) | 75,600 | 794,556 | ||||
IB Acquisition Corp.(a) | 81,000 | 807,975 | ||||
Inflection Point Acquisition Corp. II - Class A(a) | 73,515 | 779,259 | ||||
Keen Vision Acquisition Corp.(a) | 21,815 | 231,130 | ||||
Learn CW Investment Corp. - Class A(a) | 74,717 | 814,415 | ||||
Legato Merger Corp. III(a) | 80,000 | 809,064 | ||||
Lionheart Holdings(a) | 70,000 | 700,000 | ||||
Nabors Energy Transition Corp. II(a) | 70,522 | 742,597 | ||||
Quetta Acquisition Corp.(a) | 48,412 | 501,064 | ||||
RF Acquisition Corp. II(a) | 70,000 | 704,550 | ||||
SilverBox Corp. III - Class A(a) | 77,500 | 821,500 | ||||
SK Growth Opportunities Corp. - Class A(a) | 25,000 | 278,000 | ||||
Spark I Acquisition Corp.(a) | 28,209 | 291,963 | ||||
Spring Valley Acquisition Corp. II - Class A(a) | 78,522 | 872,379 | ||||
TOTAL SPECIAL PURPOSE ACQUISITION | ||||||
COMPANIES (SPACS) (Cost $17,070,498) | 17,461,366 | |||||
Contracts | Value | |||||
RIGHTS - 0.3% | ||||||
Bayview Acquisition Corp., Expires 06/15/2025, Exercise Price $10.00(a) | 47,015 | 9,168 | ||||
Black Hawk Acquisition Corp., Expires 06/20/2025, Exercise Price $10.00(a) | 5,000 | 5,950 | ||||
Bowen Acquisition Corp., Expires 01/14/2025, Exercise Price $10.00(a) | 41,373 | 5,482 | ||||
Contracts | Value | |||||
Bukit Jalil Global Acquisition 1 Ltd., Expires 12/30/2024, Exercise Price $10.00(a) | 47,015 | $7,052 | ||||
ESH Acquisition Corp., Expires 12/13/2024, Exercise Price $10.00(a) | 37,612 | 4,700 | ||||
IB Acquisition Corp., Expires 09/28/2025, Exercise Price $10.00(a) | 81,000 | 7,517 | ||||
Quetta Acquisition Corp., Expires 11/30/2024, Exercise Price $1.00(a) | 2,821 | 3,018 | ||||
TOTAL RIGHTS (Cost $40,196) | 42,887 | |||||
WARRANTS - 0.1% | ||||||
99 Acquisition Group, Inc., Expires 10/09/2028, Exercise Price $11.50(a) | 47,015 | 1,552 | ||||
Alchemy Investments Acquisition Corp. 1, Expires 06/26/2028, Exercise Price $11.50(a) | 23,507 | 3,291 | ||||
Bukit Jalil Global Acquisition 1 Ltd., Expires 08/21/2028, Exercise Price $11.50(a) | 23,507 | 564 | ||||
Colombier Acquisition Corp. II, Expires 12/31/2028, Exercise Price $11.50(a) | 15,671 | 4,701 | ||||
Inflection Point Acquisition Corp. II, Expires 07/17/2028, Exercise Price $11.50(a) | 23,507 | 2,226 | ||||
Keen Vision Acquisition Corp., Expires 09/15/2028, Exercise Price $11.50(a) | 21,815 | 1,362 | ||||
Spark I Acquisition Corp., Expires 11/27/2028, Exercise Price $11.50(a) | 14,105 | 2,610 | ||||
TOTAL WARRANTS (Cost $17,878) | 16,306 | |||||
TOTAL INVESTMENTS - 100.0% (Cost $17,128,572) | $17,520,559 | |||||
Money Market Deposit Account - 4.8%(b) | 843,937 | |||||
Liabilities in Excess of Other Assets - (4.8)% | (835,518) | |||||
TOTAL NET ASSETS - 100.0% | $17,528,978 | |||||
(a) | Non-income producing security. |
(b) | The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based on market conditions and is subject to change daily. The rate as of June 30, 2024 was 5.28%. |
10 |
Level 1 | Level 2 | Level 3 | Total | |||||||||
Investments: | ||||||||||||
Special Purpose Acquisition Companies (SPACs) | $15,323,629 | $2,137,737 | $ — | $17,461,366 | ||||||||
Rights | 16,021 | 26,866 | — | 42,887 | ||||||||
Warrants | 12,334 | 3,972 | — | 16,306 | ||||||||
Total Investments | $15,351,983 | $2,168,575 | $— | $17,520,559 | ||||||||
11 |
Horizon Kinetics Blockchain Development ETF | Horizon Kinetics Energy and Remediation ETF | Horizon Kinetics Inflation Beneficiaries ETF | Horizon Kinetics Medical ETF | Horizon Kinetics SPAC Active ETF | |||||||||||
ASSETS | |||||||||||||||
Investments, at value | $8,893,248 | $3,398,557 | $732,618,532 | $16,772,296 | $17,520,559 | ||||||||||
Cash - interest bearing deposit account | 1,259,630 | 155,529 | 55,647,181 | 1,136,329 | 843,937 | ||||||||||
Dividends and interest receivable | 6,502 | 4,783 | 1,277,656 | 42,663 | 3,352 | ||||||||||
Security lending income receivable | 5,004 | 7 | 7,254 | 354 | — | ||||||||||
Receivable for investments sold | — | — | 17,849 | — | — | ||||||||||
Total assets | 10,164,384 | 3,558,876 | 789,568,472 | 17,951,642 | 18,367,848 | ||||||||||
LIABILITIES: | |||||||||||||||
Payable upon return of securities loaned | 311,329 | — | 3,284,744 | 190,500 | — | ||||||||||
Payable to adviser | 6,816 | 2,451 | 491,355 | 12,202 | 12,220 | ||||||||||
Payable for investments purchased | — | 205 | 34,999,991 | — | 826,650 | ||||||||||
Total liabilities | 318,145 | 2,656 | 38,776,090 | 202,702 | 838,870 | ||||||||||
NET ASSETS | $9,846,239 | $3,556,220 | $750,792,382 | $17,748,940 | $17,528,978 | ||||||||||
Net Assets Consists of: | |||||||||||||||
Paid-in capital | $9,372,805 | $3,293,442 | $785,845,957 | $10,193,727 | $17,171,323 | ||||||||||
Total distributable earnings/(accumulated losses) | 473,434 | 262,778 | (35,053,575) | 7,555,213 | 357,655 | ||||||||||
Total net assets | $9,846,239 | $3,556,220 | $750,792,382 | $17,748,940 | $17,528,978 | ||||||||||
Net assets | $9,846,239 | $3,556,220 | $750,792,382 | $17,748,940 | $17,528,978 | ||||||||||
Shares issued and outstanding(a) | 400,000 | 125,000 | 22,575,000 | 594,946 | 177,484 | ||||||||||
Net asset value per share | $24.62 | $28.45 | $33.26 | $29.83 | $98.76 | ||||||||||
Cost: | |||||||||||||||
Investments, at cost | $8,136,788 | $3,161,763 | $724,569,902 | $9,307,134 | $17,128,572 | ||||||||||
Loaned Securities: | | | | | | ||||||||||
at value (included in investments) | $280,284 | $— | $3,104,859 | $188,560 | $— | ||||||||||
(a) | Unlimited shares authorized without par value. |
12 |
Horizon Kinetics Blockchain Development ETF | Horizon Kinetics Energy and Remediation ETF | Horizon Kinetics Inflation Beneficiaries ETF | Horizon Kinetics Medical ETF | Horizon Kinetics SPAC Active ETF | |||||||||||
INVESTMENT INCOME: | |||||||||||||||
Dividend income | $75,730 | $39,842 | $8,577,296 | $174,579 | $— | ||||||||||
Less: Dividend withholding taxes | (5,224) | (1,422) | (440,736) | (5,897) | — | ||||||||||
Less: Issuance fees | — | — | — | (1,931) | — | ||||||||||
Interest income | 22,538 | 3,910 | 618,705 | 20,992 | 19,554 | ||||||||||
Securities lending income | 9,183 | 292 | 44,976 | 872 | — | ||||||||||
Total investment income | 102,227 | 42,622 | 8,800,241 | 196,464 | 19,555 | ||||||||||
EXPENSES: | |||||||||||||||
Investment advisory fee | 36,748 | 14,411 | 2,660,683 | 72,891 | 69,384 | ||||||||||
Other expenses and fees | — | — | — | — | 239 | ||||||||||
Total expenses | 36,748 | 14,411 | 2,660,683 | 72,891 | 69,623 | ||||||||||
Net investment income/(loss) | 65,479 | 28,211 | 6,139,558 | 115,724 | (50,069) | ||||||||||
REALIZED AND UNREALIZED GAIN | |||||||||||||||
Net realized gain/(loss) from: | |||||||||||||||
Investments | 1,608 | (500) | (8,533,888) | 7,139 | 335,986 | ||||||||||
Foreign currency translation | (111) | (10) | (19,022) | — | — | ||||||||||
Net realized gain/(loss) | 1,497 | (510) | (8,552,910) | 7,139 | 335,986 | ||||||||||
Net change in unrealized appreciation/depreciation on: | |||||||||||||||
Investments | 23,915 | 285,360 | 36,870,280 | 960,520 | 20,877 | ||||||||||
Foreign currency translation | (67) | — | (13,371) | — | — | ||||||||||
Net change in unrealized appreciation/depreciation | 23,848 | 285,360 | 36,856,909 | 960,520 | 20,877 | ||||||||||
Net realized and unrealized gain | 25,345 | 284,850 | 28,303,999 | 967,659 | 356,863 | ||||||||||
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS | $90,824 | $313,061 | $34,443,557 | $1,083,383 | $306,794 | ||||||||||
13 |
Horizon Kinetics Blockchain Development ETF | Horizon Kinetics Energy and Remediation ETF | |||||||||||
Period ended June 30, 2024 (Unaudited) | Year ended December 31, 2023 | Period ended June 30, 2024 (Unaudited) | Period ended December 31, 2023(a) | |||||||||
OPERATIONS: | ||||||||||||
Net investment income | $65,480 | $45,401 | $28,211 | $43,088 | ||||||||
Net realized gain/(loss) | 1,497 | (86,869) | (510) | 98,230 | ||||||||
Net change in unrealized appreciation/(depreciation) | 23,848 | 969,713 | 285,360 | (48,565) | ||||||||
Net increase in net assets from operations | 90,824 | 928,245 | 313,061 | 92,753 | ||||||||
DISTRIBUTIONS TO SHAREHOLDERS: | ||||||||||||
Distributions to shareholders | — | (46,741) | — | (43,551) | ||||||||
Total distributions to shareholders | — | (46,741) | — | (43,551) | ||||||||
CAPITAL TRANSACTIONS: | ||||||||||||
Creations | 3,026,367 | 3,874,615 | — | 4,492,892 | ||||||||
Redemptions | — | — | — | (1,298,935) | ||||||||
Net increase (decrease) in net assets from capital transactions | 3,026,367 | 3,874,615 | — | 3,193,957 | ||||||||
Net increase in net assets | 3,117,191 | 4,756,119 | 313,061 | 3,243,159 | ||||||||
NET ASSETS: | ||||||||||||
Beginning of the period | 6,729,048 | 1,972,929 | 3,243,159 | — | ||||||||
End of the period | $9,846,239 | $6,729,048 | $3,556,220 | $3,243,159 | ||||||||
SHARES TRANSACTIONS | ||||||||||||
Creations | 125,000 | 175,000 | — | 175,000 | ||||||||
Redemptions | — | — | — | (50,000) | ||||||||
Total increase in shares outstanding | 125,000 | 175,000 | — | 125,000 | ||||||||
(a) | Inception date of the Fund was February 21, 2023. |
14 |
Horizon Kinetics Inflation Beneficiaries ETF | Horizon Kinetics Medical ETF | |||||||||||
Period ended June 30, 2024 (Unaudited) | Year ended December 31, 2023 | Period ended June 30, 2024 (Unaudited) | Year ended December 31, 2023 | |||||||||
OPERATIONS: | ||||||||||||
Net investment income | $6,139,558 | $15,975,008 | $115,724 | $240,646 | ||||||||
Net realized gain/(loss) | (8,552,910) | 16,684,952 | 7,139 | 1,465,942 | ||||||||
Net change in unrealized appreciation/(depreciation) | 36,856,909 | (30,515,810) | 960,520 | (2,881,253) | ||||||||
Net increase/(decrease) in net assets from operations | 34,443,557 | 2,144,150 | 1,083,383 | (1,174,665) | ||||||||
DISTRIBUTIONS TO SHAREHOLDERS: | ||||||||||||
Distributions to shareholders | (6,131,226) | (15,203,112) | — | (977,063) | ||||||||
Total distributions to shareholders | (6,131,226) | (15,203,112) | — | (977,063) | ||||||||
CAPITAL TRANSACTIONS: | ||||||||||||
Creations | 203,530,165 | 26,617,590 | — | 1,561,025 | ||||||||
Redemptions | (154,962,082) | (613,869,710) | — | (2,023,265) | ||||||||
Net increase (decrease) in net assets from capital transactions | 48,568,083 | (587,252,120) | — | — | ||||||||
Net increase (decrease) in net assets | 76,880,414 | (600,311,082) | 1,081,913 | (2,613,968) | ||||||||
NET ASSETS: | ||||||||||||
Beginning of the period | 673,911,968 | 1,274,223,050 | 16,665,557 | 19,279,525 | ||||||||
End of the period | $750,792,382 | $673,911,968 | $17,748,940 | $16,665,557 | ||||||||
SHARES TRANSACTIONS | ||||||||||||
Creations | 6,300,000 | 825,000 | — | 50,343 | ||||||||
Redemptions | (5,100,000) | (19,950,000) | — | (66,562) | ||||||||
Total increase/(decrease) in shares outstanding | 1,200,000 | (19,125,000) | — | (16,219) | ||||||||
15 |
Horizon Kinetics SPAC Active ETF | ||||||
Period ended June 30, 2024 (Unaudited) | Period ended December 31, 2023(a) | |||||
OPERATIONS: | ||||||
Net investment loss | $(50,069) | $(66,526) | ||||
Net realized gain | 335,986 | 144,306 | ||||
Net change in unrealized appreciation | 20,877 | 685,225 | ||||
Net increase in net assets from operations | 306,794 | 763,005 | ||||
DISTRIBUTIONS TO SHAREHOLDERS: | ||||||
Distributions to shareholders | — | (423,706) | ||||
Total distributions to shareholders | — | (423,706) | ||||
CAPITAL TRANSACTIONS: | ||||||
Creations | 1,960,846 | 9,580,496 | ||||
Redemptions | (973,816) | (1,068,712) | ||||
Net increase in net assets from capital transactions | 987,030 | 8,511,784 | ||||
Net increase in net assets | 1,293,824 | 8,851,083 | ||||
NET ASSETS: | ||||||
Beginning of the period | 16,235,154 | 7,384,071 | ||||
End of the period | $17,528,978 | $16,235,154 | ||||
SHARES TRANSACTIONS | ||||||
Creations | — | 100,000 | ||||
Redemptions | — | (11,146) | ||||
Total increase in shares outstanding | — | 88,854 | ||||
(a) | Inception date of the Fund was January 27, 2023. |
16 |
Period Ended June 30, 2024 (Unaudited) | Period Ended December 31, 2023(a) | |||||
PER SHARE DATA: | ||||||
Net asset value, beginning of period | $25.95 | $24.71 | ||||
INVESTMENTS OPERATIONS: | ||||||
Net investment income(b) | 0.25 | 0.39 | ||||
Net realized and unrealized gain on investments | 2.25 | 1.20 | ||||
Total from investment operations | 2.50 | 1.59 | ||||
LESS DISTRIBUTIONS FROM: | ||||||
From net investment income | — | (0.35) | ||||
Total distributions | — | (0.35) | ||||
Net asset value, end of period | $28.45 | $25.95 | ||||
Total returm(c) | 9.65% | 6.39% | ||||
SUPPLEMENTAL DATA AND RATIOS: | ||||||
Net assets, end of period (in thousands) | $3,556 | $3,243 | ||||
Ratio of expenses to average net assets(d) | 0.85% | 0.85% | ||||
Ratio of net investment income to average net assets(d) | 1.66% | 1.76% | ||||
Portfolio turnover rate(c)(e) | —% | 2% | ||||
(a) | Inception date of the Fund was February 21, 2023. |
(b) | Net investment income per share has been calculated based on average shares outstanding during the period. |
(c) | Not annualized for periods less than one year. |
(d) | Annualized for periods less than one year. |
(e) | Portfolio turnover rate excludes in-kind transactions. |
17 |
Period Ended June 30, 2024 (Unaudited) | Year Ended December 31, | |||||||||||||||||
2023 | 2022 | 2021 | 2020 | 2019 | ||||||||||||||
PER SHARE DATA: | ||||||||||||||||||
Net asset value, beginning of period | $96.94 | $93.91 | $98.92 | $100.24 | $98.28 | $97.46 | ||||||||||||
INVESTMENTS OPERATIONS: | ||||||||||||||||||
Net investment income (loss)(a) | (0.40) | (0.36) | 0.89 | (0.15) | 0.25 | 1.39 | ||||||||||||
Net realized and unrealized gain on investments | 2.22 | 5.92 | (4.92) | (1.17) | 1.91 | 1.01 | ||||||||||||
Total from investment operations | 1.82 | 5.56 | (4.03) | (1.32) | 2.16 | 2.40 | ||||||||||||
LESS DISTRIBUTIONS FROM: | ||||||||||||||||||
From net investment income | — | (2.50) | (0.87) | — | (0.22) | (1.58) | ||||||||||||
From net realized gains | — | (0.03) | (0.11) | — | — | — | ||||||||||||
Total distributions | — | (2.53) | (0.98) | — | (0.22) | (1.58) | ||||||||||||
ETF transaction fees per share | — | — | 0.00(g) | 0.00(g) | 0.02 | — | ||||||||||||
Net asset value, end of period | $98.76 | $96.94 | $93.91 | $98.92 | $100.24 | $98.28 | ||||||||||||
Total return(b) | 1.89% | 5.92% | (4.07)% | (1.32)% | 2.23% | 2.47% | ||||||||||||
SUPPLEMENTAL DATA AND RATIOS: | ||||||||||||||||||
Net assets, end of period (in thousands) | $17,529 | $16,235 | $7,384 | $2,626 | $2,642 | $3,482 | ||||||||||||
Ratio of expenses to average net assets: | ||||||||||||||||||
Before expense reimbursement(c) | 0.85% | 1.05% | 2.76% | 2.35% | 2.16% | 2.01% | ||||||||||||
After expense reimbursement(c)(e) | 0.85% | 0.79% | 0.95% | 0.95% | 0.95% | 0.95% | ||||||||||||
Ratio of net investment loss to average net assets(c) | (0.61)% | (0.48)% | 0.93% | (0.15)% | 0.25% | 1.14% | ||||||||||||
Portfolio turnover rate(b)(d) | 68% | 179%(f) | 0% | 0% | 0% | 0% | ||||||||||||
(a) | Net investment income (loss) per share has been calculated based on average shares outstanding during the period. |
(b) | Not annualized for periods less than one year. |
(c) | Annualized for periods less than one year. |
(d) | Portfolio turnover rate excludes in-kind transactions. |
(e) | See Note 3 of financial statements, Investment Advisory and Other Agreements, for the waiver and expense reimbursement discussion. |
(f) | Excludes purchases in the amount of $2,519,570 and sales in the amount of $5,569,517 due to the Fund’s change in investment strategy (See Note 1). |
(g) | Amount represents less than $0.005 per share. |
18 |
Period Ended June 30, 2024 (Unaudited) | Year Ended December 31, | |||||||||||||||||
2023 | 2022 | 2021 | 2020 | 2019 | ||||||||||||||
PER SHARE DATA: | ||||||||||||||||||
Net asset value, beginning of period | $28.01 | $31.55 | $30.78 | $28.13 | $26.53 | $23.47 | ||||||||||||
INVESTMENTS OPERATIONS: | ||||||||||||||||||
Net investment income(a) | 0.19 | 0.40 | 0.27 | 0.25 | 0.29 | 0.33 | ||||||||||||
Net realized and unrealized gain (loss) on investments | 1.63 | (2.30) | 1.02 | 2.73 | 2.11 | 3.43 | ||||||||||||
Total from investment operations | 1.82 | (1.90) | 1.29 | 2.98 | 2.40 | 3.76 | ||||||||||||
LESS DISTRIBUTIONS FROM: | ||||||||||||||||||
From net investment income | — | (0.40) | (0.36) | (0.26) | (0.31) | (0.35) | ||||||||||||
From net realized gains | — | (1.24) | (0.16) | (0.07) | (0.49) | (0.35) | ||||||||||||
Total distributions | — | (1.64) | (0.52) | (0.33) | (0.80) | (0.70) | ||||||||||||
ETF transaction fees per share | — | 0.00(b) | 0.00(b) | 0.00(b) | 0.00(b) | 0.00(b) | ||||||||||||
Net asset value, end of period | $29.83 | $28.01 | $31.55 | $30.78 | $28.13 | $26.53 | ||||||||||||
Total return(c) | 6.50% | -6.03% | 4.21% | 10.59% | 9.04% | 16.04% | ||||||||||||
SUPPLEMENTAL DATA AND RATIOS: | ||||||||||||||||||
Net assets, end of period (in thousands) | $17,749 | $16,666 | $19,280 | $16,188 | $15,462 | $15,442 | ||||||||||||
Ratio of expenses to average net assets: | ||||||||||||||||||
Before expense reimbursement(d) | 0.85% | 1.08% | 2.21% | 2.18% | 2.26% | 2.34% | ||||||||||||
After expense reimbursement(d)(f) | 0.85% | 0.85% | 1.39% | 1.39% | 1.39% | 1.39% | ||||||||||||
Ratio of net investment income to average net assets(d) | 1.35% | 1.29% | 0.89% | 0.84% | 1.12% | 1.34% | ||||||||||||
Portfolio turnover rate(c)(e) | —% | 15% | 3% | 1% | 7% | 6% | ||||||||||||
(a) | Net investment income per share has been calculated based on average shares outstanding during the year. |
(b) | Amount represents less than $0.005 per share. |
(c) | Not annualized for periods less than one year. |
(d) | Annualized for periods less than one year. |
(e) | Portfolio turnover rate excludes in-kind transactions. |
(f) | See Note 3 of financial statements, Investment Advisory and Other Agreements, for the waiver and expense reimbursement discussion. |
19 |
Period Ended June 30, 2024 (Unaudited) | Year Ended December 31, 2023 | Period Ended December 31, 2022(a) | |||||||
PER SHARE DATA: | |||||||||
Net asset value, beginning of period | $24.47 | $19.73 | $25.23 | ||||||
INVESTMENTS OPERATIONS: | |||||||||
Net investment income(b) | 0.18 | 0.31 | 0.08 | ||||||
Net realized and unrealized gain (loss) on investments | (0.03) | 4.60 | (5.51) | ||||||
Total from investment operations | 0.15 | 4.91 | (5.43) | ||||||
LESS DISTRIBUTIONS FROM: | |||||||||
From net investment income | — | (0.17) | (0.07) | ||||||
Total distributions | — | (0.17) | (0.07) | ||||||
Net asset value, end of period | $24.62 | $24.47 | $19.73 | ||||||
Total return(c) | 0.59% | 24.86% | -21.50% | ||||||
SUPPLEMENTAL DATA AND RATIOS: | |||||||||
Net assets, end of period (in thousands) | $9,846 | $6,729 | $1,973 | ||||||
Ratio of expenses to average net assets(d) | 0.85% | 0.85% | 0.85% | ||||||
Ratio of net investment income to average net assets(d) | 1.51% | 1.44% | 0.90% | ||||||
Portfolio turnover rate(c)(e) | 1% | 10% | 5% | ||||||
(a) | Inception date of the Fund was August 1, 2022. |
(b) | Net investment income per share has been calculated based on average shares outstanding during the year. |
(c) | Not annualized for periods less than one year. |
(d) | Annualized for periods less than one year. |
(e) | Portfolio turnover rate excludes in-kind transactions. |
20 |
Period Ended June 30, 2024 (Unaudited) | Year Ended December 31, | Period Ended December 31, 2021(a) | ||||||||||
2023 | 2022 | |||||||||||
PER SHARE DATA: | ||||||||||||
Net asset value, beginning of period | $31.53 | $31.46 | $31.21 | $25.00 | ||||||||
INVESTMENTS OPERATIONS: | ||||||||||||
Net investment income(b) | 0.31 | 0.49 | 0.53 | 0.30 | ||||||||
Net realized and unrealized gain on investments | 1.72 | 0.08 | 0.24 | 6.19 | ||||||||
Total from investment operations | 2.03 | 0.57 | 0.77 | 6.49 | ||||||||
LESS DISTRIBUTIONS FROM: | ||||||||||||
From net investment income | (0.30) | (0.50) | (0.52) | (0.27) | ||||||||
From net realized gains | — | — | — | (0.01) | ||||||||
Total distributions | (0.30) | (0.50) | (0.52) | (0.28) | ||||||||
Net asset value, end of period | $33.26 | $31.53 | $31.46 | $31.21 | ||||||||
Total return(c) | 6.50% | 1.86% | 2.57% | 26.05% | ||||||||
SUPPLEMENTAL DATA AND RATIOS: | ||||||||||||
Net assets, end of period (in thousands) | $750,792 | $673,912 | $1,274,223 | $868,512 | ||||||||
Ratio of expenses to average net assets(d) | 0.85% | 0.85% | 0.85% | 0.85% | ||||||||
Ratio of net investment income to average net assets(d) | 1.96% | 1.56% | 1.73% | 1.02% | ||||||||
Portfolio turnover rate(c)(e) | 6% | 10% | 9% | 0%(f) | ||||||||
(a) | Inception date of the Fund was January 11, 2021. |
(b) | Net investment income per share has been calculated based on average shares outstanding during the year. |
(c) | Not annualized for periods less than one year. |
(d) | Annualized for periods less than one year. |
(e) | Portfolio turnover rate excludes in-kind transactions. |
(f) | Amount represents less than 0.5%. |
21 |
22 |
Level 1 – | Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access. |
Level 2 – | Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data. |
23 |
Level 3 – | Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Fund’s own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available. |
24 |
25 |
26 |
For the Fiscal Period Ended June 30, 2024 | Ordinary Income (1) | Long-Term Capital Gains | ||||
BCDF | $— | $ — | ||||
NVIR | $— | $— | ||||
INFL | $6,131,226 | $— | ||||
MEDX | $— | $— | ||||
SPAQ | $— | $— | ||||
For the Fiscal Year/Period Ended December 31, 2023 | Ordinary Income (1) | Long-Term Capital Gains | ||||
BCDF | $46,741 | $ — | ||||
NVIR | 43,551 | — | ||||
INFL | 15,203,112 | — | ||||
MEDX | 240,580 | 736,483 | ||||
SPAQ | 423,706 | — | ||||
(1) | Ordinary income may include short-term capital gains. |
27 |
BCDF | NVIR | INFL | MEDX | SPAQ | |||||||||||
Federal Tax Cost of Investments | $6,373,627 | $3,304,645 | $707,013,331 | $10,613,866 | $16,155,956 | ||||||||||
Gross Tax Unrealized Appreciation | $840,979 | $161,280 | $48,980,324 | $7,574,137 | $380,270 | ||||||||||
Gross Tax Unrealized Depreciation | (139,205) | (210,052) | (81,536,552) | (1,145,956) | (290,412) | ||||||||||
Net Tax Unrealized Appreciation (Depreciation) | 701,774 | (48,772) | (32,556,228) | 6,428,181 | 89,858 | ||||||||||
Undistributed Ordinary Income | 26,275 | — | 721,386 | 22,301 | 100,965 | ||||||||||
Undistributed Long-Term Gains | — | — | — | 21,348 | — | ||||||||||
Other Accumulated Gain (Loss) | (345,439) | (1,511) | (31,531,064) | — | (139,962) | ||||||||||
Total Distributable Earnings/(Accumulated Losses) | $382,610 | $(50,283) | $(63,365,906) | $6,471,830 | $50,861 | ||||||||||
Indefinite Short-Term Capital Loss Carryover | Indefinite Long-Term Capital Loss Carryover | Post-October Losses | |||||||
Horizon Kinetics Blockchain Development ETF | $(345,439) | $— | $ — | ||||||
Horizon Kinetics Energy and Remediation ETF | (1,511) | — | — | ||||||
Horizon Kinetics Inflation Beneficiaries ETF | (9,415,612) | (22,115,452) | — | ||||||
Horizon Kinetics Medical ETF | — | — | — | ||||||
Horizon Kinetics SPAC Active ETF | — | (139,962) | — | ||||||
Realized Gains | Realized Losses | |||||
Horizon Kinetics Blockchain Development ETF | $— | $— | ||||
Horizon Kinetics Energy and Remediation ETF | 6,515 | (6,955) | ||||
Horizon Kinetics Inflation Beneficiaries ETF | 37,504,290 | (38,615,655) | ||||
Horizon Kinetics Medical ETF | — | — | ||||
Horizon Kinetics SPAC Active ETF | 25,514 | (361) | ||||
28 |
Purchases | Sales | Creations In-Kind | Redemptions In -Kind | |||||||||
Horizon Kinetics Blockchain Development ETF | $359,278 | $57,099 | $2,453,074 | $— | ||||||||
Horizon Kinetics Energy and Remediation ETF | 16,130 | 100 | — | — | ||||||||
Horizon Kinetics Inflation Beneficiaries ETF | 50,106,908 | 39,025,975 | 191,462,421 | 146,526,941 | ||||||||
Horizon Kinetics Medical ETF | — | 125,450 | — | — | ||||||||
Horizon Kinetics SPAC Active ETF | 13,146,378 | 10,768,531 | — | 955,321 | ||||||||
Values of Securities on Loan | Fund Collateral Received* | |||||
Horizon Kinetics Blockchain Development ETF | $280,284 | $311,329 | ||||
Horizon Kinetics Inflation Beneficiaries ETF | 3,104,859 | 3,284,744 | ||||
Horizon Kinetics Medical ETF | 188,560 | 190,500 | ||||
* | The cash collateral received was invested in the U.S. Bank Money Market Deposit Account, with an overnight and continuous maturity. |
29 |
30 |
31 |
32 |
Inflation Beneficiaries ETF | 100.00% | ||
Blockchain Development ETF | 65.42% | ||
Medical ETF | 100.00% | ||
SPAC Active ETF | 0.00% | ||
Energy and Remediation ETF | 100.00% | ||
Inflation Beneficiaries ETF | 52.71% | ||
Blockchain Development ETF | 41.16% | ||
Medical ETF | 100.00% | ||
SPAC Active ETF | 0.00% | ||
Energy and Remediation ETF | 94.60% | ||
33 |
(b) | Financial Highlights are included within the financial statements filed under Item 7 of this Form. |
Item 8. Changes in and Disagreements with Accountants for Open-End Investment Companies.
There were no changes in or disagreements with accountants during the period covered by this report.
Item 9. Proxy Disclosure for Open-End Investment Companies.
There were no matters submitted to a vote of shareholders during the period covered by this report.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Investment Companies.
Pursuant to the Advisory Agreement, the Adviser has agreed to pay all expenses of the Funds, except those specified in the Funds’ Prospectus. As a result, the Adviser is responsible for compensating the Independent Trustees. Further information related to Trustee and Officer compensation for the Trust can be obtained from the Funds’ most recent SAI.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
See Item 7(a).
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable to open-end investment companies.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable to open-end investment companies.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable to open-end investment companies.
Item 15. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of trustees.
Item 16. Controls and Procedures.
(a) | The Registrant’s President and Treasurer have reviewed the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant and by the Registrant’s service provider. |
(b) | There were no changes in the Registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting. |
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
Not applicable to open-end investment companies.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable
Item 19. Exhibits.
(a) | (1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit. Not Applicable. |
(2) Any policy required by the listing standards adopted pursuant to Rule 10D-1 under the Exchange Act (17 CFR 240.10D-1) by the registered national securities exchange or registered national securities association upon which the registrant’s securities are listed. Not Applicable.
(4) Any written solicitation to purchase securities under Rule 23c-1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons. Not applicable.
(5) Change in the registrant’s independent public accountant. Provide the information called for by Item 4 of Form 8-K under the Exchange Act (17 CFR 249.308). Unless otherwise specified by Item 4, or related to and necessary for a complete understanding of information not previously disclosed, the information should relate to events occurring during the reporting period. Not applicable.
(b) | Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Furnished herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | Listed Funds Trust |
By (Signature and Title)* | /s/ Gregory C. Bakken | ||
Gregory C. Bakken, President/Principal Executive Officer |
Date | 9/6/2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)* | /s/ Gregory C. Bakken | ||
Gregory C. Bakken, President/Principal Executive Officer |
Date | 9/6/2024 |
By (Signature and Title)* | /s/ Travis G. Babich | ||
Travis G. Babich, Treasurer/Principal Financial Officer |
Date | 9/6/2024 |
* Print the name and title of each signing officer under his or her signature.